# Cozart Bioscience, Ltd.

- Location (FDA's records): Oxfordshire Ox14 4ru, GB
- FDA decisions: 6 (2001–2004): 6 510(k) clearances
- Product codes: DKZ (1), MKU (1), DJG (1), DIG (1), DIO (1), DJR (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- OraSure Technologies, Inc.: 3 (https://510kreport.com/company/orasure-technologies)

## Firms that cite its devices most
- Psychemedics Corp.: 1 (https://510kreport.com/company/psychemedics)

## Its most-cited devices
- K033743: Cozart Eia Amphetamines Oral Fluid Microplate Kit (2004), cited by 1

## Recent decisions
- K033743: Cozart Eia Amphetamines Oral Fluid Microplate Kit (Jun 3, 2004)
- K021944: Cozart Eia Cotinine Urine Kit (May 14, 2003)
- K030234: Cozart Eia Cocaine Oral Fliud Kit (Apr 28, 2003)
- K024339: Cozart Eia Opiates Oral Fluid Kit (Apr 7, 2003)
- K020920: Cozart Rapiscan Oral Fluid Drug Test - Opiate/Methadone (Nov 5, 2002)
- K011131: Methadone Microplate Eia Urine Application (Jul 31, 2001)

Source page: https://510kreport.com/company/cozart-bioscience
